STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

How 1 sources are covering this

• STATCenter·1h ago

  STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

  The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.

  Read at STAT →